VNTRF yields 7.14% · MRK yields 2.76%● Live data
📍 MRK pulled ahead of the other in Year 4
Combined, VNTRF + MRK cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of VNTRF + MRK for your $10,000?
Venator Materials PLC, together with its subsidiaries, manufactures and markets chemical products in the United Kingdom and internationally. It operates in two segments, Titanium Dioxide and Performance Additives. The Titanium Dioxide segment offers titanium dioxide (TiO2), such as rutile, anatase, and ultrafine TiO2 products for use in coatings, printing inks, PVC window frames, plastic masterbatches, cosmetics, pharmaceuticals, food, polyester and polyamide fibers, catalysts, and cosmetics products. The Performance Additives segment provides barium and zinc additives for use in coatings, films, and paper and glass fiber reinforced plastics; and colored inorganic pigments comprising iron oxides, ultramarines, specialty inorganic chemicals, and driers for construction, coatings, plastics, cosmetics, inks, catalyst, and laminates. This segment also offers wood protection chemicals for use in residential and commercial applications to prolong the life through protection from decay, fungal, and insect attack; timber treatment chemicals for use in decking, fencing, and other residential outdoor wood structures; and industrial construction products for use in telephone poles, and salt water piers and pilings. The company was incorporated in 2017 and is based in Stockton-On-Tees, the United Kingdom.
Full VNTRF Calculator →Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.
Full MRK Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.